(Q24564890)
Statements
β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma (English)
0 references
15 May 2013
0 references
73
0 references
10
0 references
3145-54
0 references
1 reference